Skip to content
10-K/A

Annual Report

Monopar Therapeutics MNPR

0001437749-26-010841

← back to feed
Filed
Apr 1, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 17, 2026 6.69M sh